TABLE 3.
The studies on materials reducing PCO.
| Surface modification | IOL optic materials | Technique | Article | |
|---|---|---|---|---|
| Drug loading modification | DOX*-CHI*-sodium TPP*/HEP* | Hydrophobic acrylic | LBL* assembly | Han et al. (2019) |
| PDA*-DOX-MPC* | Hydrophobic acrylic | Immersion | Liu et al. (2021) | |
| DOX-PAMAM*/HEP | LBL assembly | Chen et al. (2021) | ||
| PEGMA*-s-peptide-DOX | Hydrophobic acrylic | SI-RAFT | Han et al. (2020a) | |
| DOX-PEGMA-co-GMA* | Hydrophobic acrylic | Immersion | Xia et al. (2021) | |
| DOX-exosomes | Hydrophobic acrylic | Electroporation | Zhu et al. (2022) | |
| MTX* | Hydrophobic acrylic | Supercritical fluid | Ongkasin et al. (2020) | |
| MTX-PLGA* | Hydrophobic acrylic hydrophilic acrylic | Spray coating | Kassumeh et al. (2018) | |
| CsA*-PLGA | Spin coating | Lu et al. (2022) | ||
| Y27632-PLGA | Hydrophobic acrylic | Lin et al. (2019) | ||
| PEI*-(anti-T/PLL*)4-(anti-T) | Hydrophobic acrylic | LBL assembly | Sun et al. (2014) | |
| PLGA-bromfenac | Hhydrophobic acrylic | Ultrasonic spray | Zhang et al. (2022) | |
| HA*-Pac*/CHI | Silicon | LBL assembly | Huang et al. (2021) | |
| 5-Fu-CHI | PMMA | Immersion | Huang et al. (2013b) | |
| 5-Fu-PPGC* | Hydrophobic acrylic | Immersion | Xia et al. (2022) | |
| GOD*-HRP*-MSNs* | Silicon | Immersion | Huang et al. (2022) | |
| Photodynamic modification | ICG*-PLGA | Immersion | Zhang et al. (2016) | |
| α-CD-Ce6*-PPEGMA* brush | Hydrophobic acrylic | Supramolecular interaction | Tang et al. (2021) | |
| Carboxylated CuInS/ZnS quantum dots | Facial activation-immersion | Mao et al. (2020) | ||
| PDA/PEI-PMMA | Hydrophobic acrylic | Immersion | Xu et al. (2021) | |
| PDA | Hydrophobic acrylic | Immersion | Qie et al. (2022) | |
| Hydrophobic modification | RGD | Hydrophilic acrylic | Plasma | Huang et al. (2014) |
| Hydrophilic modification | PSBMA* brush coating | SI-RAFT | Wang et al. (2021c) | |
| PEG* brush | SI-RAFT | Lin et al. (2010) | ||
| HA-CHI | Silicon | LBL assembly | Lin et al. (2015) | |
| PEG | Hydrogel | Grafting | Bozukova et al. (2007) | |
| PEG | Hydrophobic acrylic | Plasma | Xu et al. (2016) | |
| EGPEMA*-co-EA* | Hydrophobic acrylic | Liu et al. (2021) |
*DOX, doxorubicin; CHI, chitosan; TPP, tripolyphosphate; HEP, heparin; PDA, polydopamine; MPC, 2-methacryloyloxyethyl phosphorylcholine; PAMAM, polyaminoamide; PEGMA, poly (ethylene glycol) methacrylate; GMA, glycidyl methacrylate; MTX, methotrexate; PLGA, poly (lactic-co-glycolic) acid; CsA, cyclosporine A; PEI, polyethylenimine; PLL, poly-L-lysine; HA, hyaluronic acid; Pac, paclitaxel; ICG, indocyanine green; PPGC, poly (polyethylene glycol methacrylate-co-glycidyl methacrylate-co-coumarin methacrylate); GOD, glucose oxidase; HRP, horseradish peroxidase; MSNs, mesoporous silica nanoparticles; α-CD-Ce6, chlorin e6 grafted α-cyclodextrin; PPEGMA, poly (poly (ethylene glycol) methacrylate); PSBMA, poly (sulfobetaine methacrylate); PEG, poly (Ethylene Glycol); LBL, layer-by-layer; EGPEMA, ethylene glycol phenyl ether methacrylate; EA, 2-(2-ethoxyethoxy) ethyl acrylate.